Publication | Closed Access

A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis

Translational MedicineAntifibrotic TherapyFibrosisMedicineIdiopathic Pulmonary FibrosisHypoxia-cleavable Delivery SystemFibroblastic Foci-targetingPulmonary FibrosisPulmonary PharmacologyBiomedical EngineeringPharmacology